Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fresenius Medical Care AG (FMS) Equity Average: 2009-2024

Historic Equity Average for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $16.5 billion.

  • Fresenius Medical Care AG's Equity Average changed N/A to $337.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.6 million, marking a year-over-year change of. This contributed to the annual value of $16.5 billion for FY2024, which is 243.25% up from last year.
  • As of FY2024, Fresenius Medical Care AG's Equity Average stood at $16.5 billion, which was up 243.25% from $16.1 billion recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Equity Average high stood at $16.5 billion for FY2024, and its period low was $14.4 billion during FY2020.
  • Its 5-year average for Equity Average is $15.6 billion, with a median of $16.1 billion in 2023.
  • In the last 5 years, Fresenius Medical Care AG's Equity Average crashed by 386.59% in 2020 and then surged by 732.66% in 2022.
  • Fresenius Medical Care AG's Equity Average (Annual) stood at $14.4 billion in 2020, then rose by 4.08% to $15.0 billion in 2021, then increased by 7.33% to $16.1 billion in 2022, then decreased by 0.12% to $16.1 billion in 2023, then increased by 2.43% to $16.5 billion in 2024.
  • Its Equity Average stands at $16.5 billion for FY2024, versus $16.1 billion for FY2023 and $16.1 billion for FY2022.